Willow Biosciences Inc. (CSE: WLLW), a leading developer of
biosynthetic production systems for plant-derived active pharmaceutical
ingredients (APIs) and intermediates, in early June announced its entry into an
exclusive joint development agreement with Noramco Inc., a leading manufacturer
of cannabinoids. Per the update, the two firms intend to collaboratively
develop a yeast-based biosynthesis platform for the production and distribution
of cannabidiol. Willow further notes that the work conducted through the
agreement has the potential to open new and larger markets for CBD and related
compounds. “Noramco is a world-class organization with a long history of
developing APIs across numerous markets and is the market leader in
synthetically-produced CBD,” Dr. Joseph Tucker, executive chairman of Willow,
stated in the news release. “They are the obvious first choice as a partner to
scale the development of our CBD biosynthesis program. Noramco’s global
leadership in the production and sales of cannabinoids to pharmaceutical
companies will naturally lead into manufacturing and sales into additional
non-pharmaceutical markets.”
To view the full press release, visit http://ibn.fm/xHYaI
About Willow Biosciences Inc.
Headquartered in Calgary, Canada, Willow and its team of
scientists are leaders in the field of biosynthetic production of high value
plant-derived compounds. Willow has applied its integrated suite of
technologies to develop manufacturing processes for numerous active
pharmaceutical ingredients with various therapeutic benefits, including cancer
treatment, pain management, and CNS disorders. In the cannabinoid field, Willow
owns proprietary yeast-based lab strains that produce CBD, tetrahydrocannabinol
(THC), and cannabigerol (CBG), as well as certain minor and novel cannabinoids.
For more information, visit the company’s website at www.WillowBio.com
NOTE TO INVESTORS: The latest news and updates
relating to WLLW are available in the company’s newsroom at http://ibn.fm/WLLW
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment